drugset / Trial / NCT06667024
Dexmedetomidine as an Intrathecal Adjuvant to Hyperbaric Bupivacaine for Postoperative Analgesia in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction Surgeries
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aimed to evaluate the effect of adding low doses of dexmedetomidine to hyperbaric bupivacaine during spinal anesthesia on post operative analgesia characteristics in Arthroscopic Anterior Cruciate Ligament Reconstruction Surgeries
Timeline
- Start
- 2023-09-01
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 4 ug | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 0.5 % | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 3 ml | Intrathecal |
Indications
No indication recorded.